- US-listed companies
- SURMODICS INC
- Income statement
SURMODICS INCSRDX
Market cap
$614.58M
P/E ratio
| 2011/09 | 2012/09 | 2013/09 | 2014/09 | 2015/09 | 2016/09 | 2017/09 | 2018/09 | 2019/09 | 2020/09 | 2021/09 | 2022/09 | 2023/09 | 2024/09 | |
| Revenue | 68 | 52 | 56 | 57 | 62 | 71 | 73 | 81 | 100 | 95 | 105 | 100 | 133 | 126 |
| Revenue growth (%) | - | |||||||||||||
| Cost of revenue | 8 | 7 | 8 | 8 | 9 | 11 | 11 | 14 | 14 | 15 | 17 | 20 | 25 | 33 |
| Research & development | - | 14 | 15 | 16 | 16 | 18 | 32 | 41 | - | - | - | - | - | - |
| Selling, general & administrative | 21 | 14 | 14 | 15 | 16 | 18 | 20 | 24 | 24 | 28 | 31 | 47 | 52 | 57 |
| Operating margin (%) | ||||||||||||||
| Operating income | -18 | 16 | 19 | 19 | 19 | 17 | 7 | -9 | 6 | -1 | 7 | -22 | 5 | -6 |
| Operating expenses | 85 | 36 | 37 | 39 | 43 | 55 | 66 | 90 | 94 | 96 | 98 | 122 | 127 | 132 |
| Income before tax | -16 | 16 | 20 | 18 | 18 | 17 | 7 | -8 | 8 | -1 | 6 | -22 | 2 | -8 |
| Pretax margin (%) | -24.3 | 31.4 | 36.3 | 32.2 | 29.5 | 23.7 | 9.6 | -9.3 | 7.6 | -1.5 | 6 | -22.5 | 1.9 | -6 |
| Provision for income taxes | -4 | 6 | 6 | 6 | 6 | 7 | 3 | -3 | -0 | -3 | 2 | 5 | 4 | 4 |
| Effective tax rate (%) | ||||||||||||||
| Net income | -13 | 10 | 15 | 12 | 12 | 10 | 4 | -4 | 8 | 1 | 4 | -27 | -2 | -12 |
| Net income margin (%) | ||||||||||||||
| Earnings per share | -0.73 | 0.59 | 1.05 | 0.88 | 0.92 | 0.77 | 0.3 | -0.34 | 0.57 | 0.08 | 0.31 | -1.96 | -0.11 | -0.82 |
| Diluted EPS | -0.73 | 0.59 | 1.03 | 0.87 | 0.9 | 0.76 | 0.29 | -0.34 | 0.55 | 0.08 | 0.3 | -1.96 | -0.11 | -0.82 |
| EBITDA | ||||||||||||||
| EBITDA margin (%) |